PrEP Adherence
Cross-source consensus on PrEP Adherence from 1 sources and 6 claims.
1 sources · 6 claims
Benefits
Dosage & preparation
Risks & contraindications
Evidence quality
Highlighted claims
- The protocol defines prevention-effective adherence as at least four oral PrEP doses per week. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
- TFV-DP below 900 fmol per punch was classified as suboptimal daily oral PrEP adherence. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
- TFV-DP above 900 fmol per punch was classified as prevention-effective PrEP adherence. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
- Follow-up assessments measured TFV-DP in dried blood spots as an objective biomarker of PrEP adherence. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
- Daily oral PrEP can virtually eliminate HIV acquisition risk when prevention-effective adherence is achieved. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial
- Sexual minority men who use stimulants have more difficulty maintaining PrEP adherence and persistence. — Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial